Genentech’s chief diversity officer Quita Highsmith is on a crusade to prove that much of what the industry believes about clinical trial diversity is wrong. By: Michael Gibney • Published Dec. 14, 2023 Among the many falsehoods surrounding diversity in clinical trials, the notion that people of color simply don’t want…

Johnson & Johnson Innovative Medicine’s director of diversity, equity and inclusion in clinical trials shares key strategies for making DEI work. By: Alexandra Pecci • Published Nov. 14, 2023 The need for diversity in clinical trials has come to an inflection point, with the FDA issuing draft guidance for how trial sponsors can…